Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Recruiting · NCT05027906 · Registry updated 2025-06-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2025-06-29 | NCT05027906 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eledon Pharmaceuticals | 5 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fundação Oswaldo Ramos - Hospital do Rim | São Paulo | Brazil | 2 |
| Liverpool University Hospitals NHS Foundation Trust - Royal Liverpool University Hospital | Liverpool | United Kingdom | 1 |
| McGill University Health Care Centre | Montreal | Canada | 2 |
| Oxford University Hospitals NHS Foundation Trust - John Radcliffe Hospital | Oxford | United Kingdom | 4 |
| Providence Health Care - St. Paul's Hospital | Vancouver | Canada | 1 |
| Royal Adelaide Hospital | Adelaide | Australia | 2 |
| Royal Prince Alfred Hospital | Camperdown | Australia | 83 |
| University of Cincinnati | Cincinnati | United States | 79 |
| Vancouver General Hospital | Vancouver | Canada | 2 |